GC1008
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Genzyme, a Sanofi Company
Overview
GC1008 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
GC1008 clinical trials
Explore related
Medical disclaimer. This page summarizes research about GC1008 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.